News | February 13, 2021
Steady performance; for Alkem Laboratories: ICICI Securities
The company continued to maintain clear FDA status across its plants and has received 12 ANDA approvals during 9MFY21
The company continued to maintain clear FDA status across its plants and has received 12 ANDA approvals during 9MFY21
The Pre-Approval Inspection (PAI) was completed on February 13, 2026, and the company is initiating corrective actions.
PendraCare Group develops, manufactures and sells innovative cardiology catheter solutions and provides design, development and manufacturing services to other global OEM’s
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
The product will be marketed by Dr. Reddy's
Earlier, he worked with Cadila Pharmaceuticals Limited, Cipla, Alkem Laboratories, and Wockhardt, and started his career with Novartis
Asthma patients are more likely to have an asthma attack during winter
Ranked 25th with an impressive growth rate of 29% among Indian pharma companies in FY 2021-22
Technology adoption helped the industry to sail through Covid-19 disruption as it understood the need to digitize, learn, and excel
Flattish volume growth and subdued new launches were key factors for last month
Subscribe To Our Newsletter & Stay Updated
